CareLit · DOI-Nachweis · Klinische Pädiatrie
Can nanotechnology help immunotherapy in glioblastoma multiforme? Tumor protein loaded nanoparticles
DOI 10.1055/s-0035-1564671
Bibliografische Angaben
Nachweis in CareLit
Autor:innenJ Belmans, SW Van Gool
ZeitschriftKlinische Pädiatrie
Ausgabe11/2015
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Glioblastoma multiforme is the most frequent primary brain tumor that despite current treatment has a dismal prognosis. Therefore a lot of effort is put in adjuvant therapies with one possibility using dendritic cells (DCs) to harness the immune system. This DC immunotherapy consists of autologous DCs ex vivo loaded with autologous tumor lysate. But the requirement for autologous cell cultures causes this therapy to…
Zitieren
Zitierempfehlung
J Belmans, SW Van Gool (2015) Can nanotechnology help immunotherapy in glioblastoma multiforme? Tumor protein loaded nanoparticles. Klinische Pädiatrie (11). https://doi.org/10.1055/s-0035-1564671
Mit CareLit weiterarbeiten